Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Antares takes cost-cutting measures:

This article was originally published in Clinica

Executive Summary

Antares Pharma has decided to close its manufacturing and assembly facilities in Minneapolis, Minnesota, and outsource these activities. The company, which is developing needle-free injectors and transdermal gel products, says it wants to focus on design and engineering rather than investing its resources in expanding its production capabilities. The company restructured its debt financing earlier this month. Its partner, Ferring Pharmaceuticals, recently launched its Vision reusable device, and Lilly is examining the possibility of using its needle-free technology with several of its pharmaceuticals.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT061246

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel